Literature DB >> 14661921

In situ blood-brain barrier transport of nanoparticles.

Joanna M Koziara1, Paul R Lockman, David D Allen, Russell J Mumper.   

Abstract

PURPOSE: Two novel types of nanoparticles were evaluated as poten tial carriers for drugs across the blood-brain barrier (BBB).
METHODS: Nanoparticles were composed of biocompatible materials including emulsifying wax (E. Wax) or Brij 72. Brij 78 and Tween 80 were used as surfactants for E. Wax nanoparticles (E78 NPs) and Brij 72 nanoparticles (E72 NPs), respectively. Both nanoparticle formulations were prepared from warm microemulsion precursors usin melted E. Wax or Brij 72 as the oil phase. Nanoparticles were radio-labeled by entrapment of [3H]cetyl alcohol, and entrapment efficiency and release of radiolabel were evaluated. The transport of E78 and E72 NPs across the BBB was measured by an in situ rat brai perfusion method.
RESULTS: Both formulations were successfully radiolabeled by entrapment of [3H]cetyl alcohol; -98% of radiolabel remained associated with nanoparticles at experimental conditions. The transfer rate (Kin) of E78 NPs from perfusion fluid into the brain was 4.1 +/- 0.5 x 10(-3) ml/s/g, and the permeability-surface area product (PA) was 4.3 +/- 0.7 x 10(-3) ml/s/g. The values for Kin and PA for E72 NPs were 5.7 +/- 1.1 x 10(-3) ml/s/g and 6.1 +/- 1.4 x 10(-3) ml/s/g, respectively.
CONCLUSIONS: For both nanoparticle types, statistically significant uptake was observed compared to [14C]sucrose, suggesting central nervous system uptake of nanoparticles. The mechanism underlying th nanoparticle brain uptake has yet to be fully understood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661921     DOI: 10.1023/b:pham.0000003374.58641.62

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.

Authors:  L L Muldoon; P G Tratnyek; P M Jacobs; N D Doolittle; G A Christoforidis; J A Frank; M Lindau; P R Lockman; S P Manninger; Y Qiang; A M Spence; S I Stupp; M Zhang; E A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 3.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  The effect of iron nanoparticles on performance of cognitive tasks in rats.

Authors:  Elena Sheida; Olga Sipailova; Sergei Miroshnikov; Elena Sizova; Svyatoslav Lebedev; Elena Rusakova; Svetlana Notova
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-16       Impact factor: 4.223

5.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

6.  Molecular dynamics simulation of drug uptake by polymer.

Authors:  M Subashini; Padma V Devarajan; Ganeshchandra S Sonavane; Mukesh Doble
Journal:  J Mol Model       Date:  2010-08-05       Impact factor: 1.810

7.  Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles.

Authors:  J M Koziara; J J Oh; W S Akers; S P Ferraris; R J Mumper
Journal:  Pharm Res       Date:  2005-08-26       Impact factor: 4.200

8.  Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.

Authors:  Tushar K Vyas; A K Babbar; R K Sharma; Shashi Singh; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2017-03-08       Impact factor: 3.246

9.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

10.  Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.

Authors:  Hui-Yun Zhang; Caleb Kesse Firempong; Yuan-Wen Wang; Wen-Qian Xu; Miao-Miao Wang; Xia Cao; Yuan Zhu; Shan-Shan Tong; Jiang-Nan Yu; Xi-Ming Xu
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.